Sarcopedia

BenignBone

Chondroblastoma

Synonyms: Codman tumour, epiphyseal chondromatous giant cell tumour

One of the few truly epiphyseal Bone tumours (along with GCT and clear cell chondrosarcoma)

Quick Facts

Behaviour

Benign

Category

Bone

Grade

Not set

Synonyms

  • Codman tumour
  • epiphyseal chondromatous giant cell tumour

Category

Bone

Behaviour

Benign

Gender

Male

Tissue of Origin

Cartilage

Epidemiology

  • Rare, 1% of primary Bone tumours
  • Peak incidence 2nd decade (adolescence)
  • Male predominance (2:1)
  • One of the few epiphyseal tumours

Clinical Features

  • Joint pain (often mistaken for arthritis)
  • Effusion of adjacent joint
  • Restricted range of motion
  • Tenderness over epiphysis

Location

  • Epiphysis of long Bones - virtually always
  • Distal femur, proximal tibia, proximal humerus most common
  • Greater trochanter and humeral head
  • Rarely small Bones of hands/feet (apophyseal location)

Imaging

  • Well-defined lytic epiphyseal lesion with sclerotic margin
  • Stippled calcification in 50%
  • MRI: extensive Bone marrow and soft tissue oedema (may mimic infection)
  • Bone scan: markedly hot - out of proportion to lesion size

Pathology

  • Chondroblasts with 'chicken-wire' calcification
  • S100-positive chondroblasts with grooved/coffee-bean nuclei
  • Scattered osteoclast-type giant cells
  • H3F3B K36M mutation in >90%

Genetics

  • H3F3B K36M mutation - Highly specific and diagnostically useful
  • Distinct from GCT which has H3F3A G34W mutation
  • Simple karyotype

Treatment

  • Curettage and Bone grafting
  • Extended curettage with adjuvants (phenol/liquid nitrogen) to reduce recurrence
  • Physis-sparing approach in skeletally immature patients
  • Denosumab: emerging role for unresectable cases

Prognosis

  • Excellent - Malignant transformation exceedingly rare
  • Recurrence rate 10–20% after curettage
  • Pulmonary implants (Benign) described - not true metastasis
  • Growth disturbance possible if physis damaged

Key Points

  • One of the few truly epiphyseal Bone tumours (along with GCT and clear cell chondrosarcoma)
  • H3F3B K36M IHC is Highly sensitive and specific for diagnosis
  • Extensive perilesional oedema on MRI is characteristic and can mislead towards aggressive diagnosis
  • Benign pulmonary implants documented - do not require treatment

Workup - Blood Tests

No blood tests required

Workup - Local Imaging

  • Plain radiograph
  • CT - assesses internal calcifications and cortical integrity
  • MRI

Workup - Biopsy

  • Biopsy if imaging uncertain
  • Histology: primitive chondroblasts with chondroid matrix; chicken wire calcifications

Workup - Staging

No staging required

Follow-up Summary

  • Post-op visit at 6 weeks; plain X-ray + MRI of primary site at 3 months post-op
  • Year 1–2: 6-monthly clinical review + plain X-ray of primary site
  • Year 3–5: Annual review; imaging only if symptomatic
  • Discharge at 5 years if no local recurrence
  • Benign pulmonary implants: if found incidentally - CT chest for characterisation; no treatment required if stable
  • Physeal monitoring in skeletally immature patients - assess for growth disturbance at each visit